These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25024282)

  • 1. Preventing autoimmunity protects against the development of hypertension and renal injury.
    Mathis KW; Wallace K; Flynn ER; Maric-Bilkan C; LaMarca B; Ryan MJ
    Hypertension; 2014 Oct; 64(4):792-800. PubMed ID: 25024282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus.
    Wolf VL; Taylor EB; Ryan MJ
    Physiol Rep; 2019 May; 7(10):e14059. PubMed ID: 31124322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease.
    Taylor EB; Ryan MJ
    J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.
    Taylor EB; Barati MT; Powell DW; Turbeville HR; Ryan MJ
    Hypertension; 2018 Apr; 71(4):719-728. PubMed ID: 29378858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal hemodynamic changes in a female mouse model of systemic lupus erythematosus.
    Dent EL; Taylor EB; Sasser JM; Ryan MJ
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1074-F1085. PubMed ID: 32150445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus.
    Venegas-Pont M; Manigrasso MB; Grifoni SC; LaMarca BB; Maric C; Racusen LC; Glover PH; Jones AV; Drummond HA; Ryan MJ
    Hypertension; 2010 Oct; 56(4):643-9. PubMed ID: 20696988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension in an experimental model of systemic lupus erythematosus occurs independently of the renal nerves.
    Mathis KW; Venegas-Pont M; Flynn ER; Williams JM; Maric-Bilkan C; Dwyer TM; Ryan MJ
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R711-9. PubMed ID: 23926131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure and albuminuria in a female mouse model of systemic lupus erythematosus: impact of long-term high salt consumption.
    Dent EL; Broome HJ; Sasser JM; Ryan MJ
    Am J Physiol Regul Integr Comp Physiol; 2020 Oct; 319(4):R448-R454. PubMed ID: 32813539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Induction of Pulmonary Inflammation, Autoimmune Gene Expression, and Ectopic Lymphoid Neogenesis Following Acute Silica Exposure in Lupus-Prone Mice.
    Chauhan PS; Wagner JG; Benninghoff AD; Lewandowski RP; Favor OK; Wierenga KA; Gilley KN; Ross EA; Harkema JR; Pestka JJ
    Front Immunol; 2021; 12():635138. PubMed ID: 33732257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.
    Haas KM; Watanabe R; Matsushita T; Nakashima H; Ishiura N; Okochi H; Fujimoto M; Tedder TF
    J Immunol; 2010 May; 184(9):4789-800. PubMed ID: 20368280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
    McMurray RW; Elbourne KB; Lagoo A; Lal S
    J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus.
    Mathis KW; Venegas-Pont M; Masterson CW; Stewart NJ; Wasson KL; Ryan MJ
    Hypertension; 2012 Mar; 59(3):673-9. PubMed ID: 22291449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.
    Bekar KW; Owen T; Dunn R; Ichikawa T; Wang W; Wang R; Barnard J; Brady S; Nevarez S; Goldman BI; Kehry M; Anolik JH
    Arthritis Rheum; 2010 Aug; 62(8):2443-57. PubMed ID: 20506300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus.
    Lin W; Seshasayee D; Lee WP; Caplazi P; McVay S; Suto E; Nguyen A; Lin Z; Sun Y; DeForge L; Balazs M; Martin F; Zarrin AA
    Arthritis Rheumatol; 2015 Jan; 67(1):215-24. PubMed ID: 25303150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice.
    Xia W; Eltrich N; Vielhauer V
    Front Immunol; 2024; 15():1377913. PubMed ID: 38799420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of autoreactive T and B lymphocytes by anti-annexin A1 antibody in a humanized NSG murine model of systemic lupus erythematosus.
    Mihaylova N; Chipinski P; Bradyanova S; Velikova T; Ivanova-Todorova E; Chausheva S; Herbáth M; Kalinova D; Prechl J; Kyurkchiev D; Tchorbanov AI
    Clin Exp Immunol; 2020 Mar; 199(3):278-293. PubMed ID: 31724735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus.
    Venegas-Pont M; Sartori-Valinotti JC; Maric C; Racusen LC; Glover PH; McLemore GR; Jones AV; Reckelhoff JF; Ryan MJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R1282-9. PubMed ID: 19193937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of B cells in murine lupus: efficacy and resistance.
    Ahuja A; Shupe J; Dunn R; Kashgarian M; Kehry MR; Shlomchik MJ
    J Immunol; 2007 Sep; 179(5):3351-61. PubMed ID: 17709552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus.
    Park MJ; Lee SH; Kim EK; Lee EJ; Park SH; Kwok SK; Cho ML
    Arthritis Rheumatol; 2016 Nov; 68(11):2717-2727. PubMed ID: 27214349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
    Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
    Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.